Related Experiment Video

Updated: Aug 16, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

[Comparison of prescriptions by pediatricians and general practitioners: a population-based study in Franche-Comté

A Bocquet1, M Chalumeau, D Bollotte

  • 1Association française de pédiatrie ambulatoire, 1, rue Auguste-Rodin, 25000 Besançon, France. Bocquet.A@wanadoo.fr

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|August 17, 2005
PubMed

Insights

Pediatrician care for children resulted in fewer consultations, prescriptions, and hospitalizations compared to general practitioners. Pediatricians also improved vaccination rates and preventive care, even for children with chronic conditions.

Area of Science:

  • Pediatric Medicine
  • General Practice
  • Healthcare Management

Context:

  • Comparison of medical management strategies for pediatric patients.
  • Retrospective cohort study analyzing health insurance data (2001-2002).
  • Focus on differences between private pediatricians and general practitioners.

Purpose:

  • To compare the medical management of children by private pediatricians versus general practitioners.
  • To analyze prescription rates, consultations, and hospitalizations.
  • To evaluate differences in antibiotic use, vaccination, and preventive care.

Summary:

  • Pediatrician management was linked to 25% fewer consultations and 6% fewer hospitalizations.
  • Pediatricians prescribed fewer drugs, lab tests, and therapies, with significantly lower antibiotic use.
  • Children under pediatric care showed higher vaccination coverage and increased preventive measures for rickets and cavities.

Impact:

  • Highlights significant differences in pediatric care approaches between general practitioners and pediatricians.
  • Suggests potential for optimizing child healthcare delivery and resource utilization.
  • Underscores the need for further research controlling for patient health status.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...